GenMont Biotech Inc (3164) — Long-term Investment Intensity
GenMont Biotech Inc (3164) has a Long-term Investment Intensity of 2.2% as of September 2019. Long-term investments of NT$36.30 Million represent 2.2% of total assets of NT$1.64 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check GenMont Biotech Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
GenMont Biotech Inc Long-term Investment Intensity (2013–2018)
This chart shows how GenMont Biotech Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of September 2019, the intensity stands at 2.2%, reflecting long-term investments of NT$36.30 Million against total assets of NT$1.64 Billion TWD. For the complete balance sheet picture, see how large is GenMont Biotech Inc's balance sheet.
Annual Long-term Investment Intensity for GenMont Biotech Inc (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for GenMont Biotech Inc from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of GenMont Biotech Inc for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 2.5% | NT$41.85 Million | NT$1.66 Billion | ▼ -0.2 pp |
| 2017 | 2.7% | NT$40.35 Million | NT$1.50 Billion | ▼ 0.0 pp |
| 2016 | 2.7% | NT$37.94 Million | NT$1.40 Billion | ▲ +1.2 pp |
| 2015 | 1.5% | NT$23.89 Million | NT$1.63 Billion | ▲ +0.1 pp |
| 2014 | 1.3% | NT$23.39 Million | NT$1.74 Billion | ▲ +0.1 pp |
| 2013 | 1.3% | NT$17.32 Million | NT$1.37 Billion | — |